Wednesday, February 3, 2010

Dishman Pharmaceuticals & Chemicals NSE NOTICES

Dishman Pharmaceuticals And Chemicals Limited has informed the Exchange that the Board of Directors of the Company has, in its meeting held on January 12, 2010, approved the proposal of issue of Non- Convertible Debentures (NCD) up to an amount of INR 750 million, for augmenting medium to long term resources of the Company, including regular capital expenditure.
Source: NSE
Courtesy moneycontrol.com








Also check

No comments:

Post a Comment